Медицинская литература. Новинки

 

 

 

 

 

 

Параганглиомы головы и шеи: эпидемиология, лучевая диагностика, лечение

Вы можете загрузить полный текст статьи в формате pdf

Параганглиомы головы и шеи являются крайне редкими опухолями. За весь период профессиональной деятельности врач-рентгенолог может встретить единичные случаи параганглиом, поэтому важно знать основные диагностические признаки при подозрении на данное заболевание, чтобы своевременно и с минимальным хирургическим риском выполнить оперативное вмешательство. Целью данного обзора является изучение наиболее распространенных локализаций параганглиом области головы и шеи и описание ключевых визуализационных характеристик, необходимых для правильной постановки диагноза и дифференциальной диагностики.

Ключевые слова:
параганглиома, хемодектома, опухоли головы и шеи, УЗИ, КТ, МРТ, paraganglioma, chemodectoma, head neck tumors, US, CT, MRI

Литература:
1.Meli G.A., Chiaramonte R., Cavallaro T., Puglisi C., Pero G. Carotid body paraganglioma. Diagnosis and treatment by angiography. Neuroradiol. J. 2006; 19: 645-648.
2.Chapman D.B., Lippert D., Geer C.P., Edwards H.D., Russell G.B., Rees C.J., Browne J.D. Clinical, histopathologic, and radiographic indicators of malignancy in head and neck paragangliomas. Otolaryngol. Head Neck Surg. 2010; 143: 531-537. DOI:10.1016/j.otohns.2010.05.031.
3.Boedeker C.C., Ridder G.J., Schipper J. Paragangliomas of the head and neck: diagnosis and treatment. Familial Cancer. 2005; 4: 55-59. DOI:10.1007/s10689-004-2154-z.
4.Mediouni A., Ammari S., Wassef M., Gimenez-Roqueplo A.P., Laredo J.D., Duet M., Tran Ba Huy P., Oker N. Malignant head/neck paragangliomas. Comparative study. Eur. Ann. Otorhinolaryngol. Head Neck Dis. 2014; 131(3): 159-166. DOI: 10.1016/j.anorl.2013.05.003.
5.Kaklikkaya I., Imamoglu M., Isik A.U., Ozcan F. Carotid body tumors. Turk. J. Thorac. Cardiovasc. Surg. 1998; 6: 323-329.
6.Шубин А.А. Ангиохирургические аспекты лечения хемо дектом шеи: Дисс. … д-ра мед. наук. М., 2003. 314 с.
7.Sajid M.S., Hamilton G., Baker D.M.; Joint Vascular Research Group. A Multicenter review of carotid body tumour management. Eur. J. Vasc. Endovasc. Surg. 2007; 34 (2): 127-130.DOI:10.1016/j.ejvs.2007.01.015.
8.Welander J., Andreasson A., Brauckhoff M., Backdahl M., Larsson C., Gimm O., Soderkvist P. Frequent EPAS1/HIF2? exons 9 and 12 mutations in non-familial pheochromocytoma. Endocr. Relat. Cancer. 2014; 21 (3): 495-504. DOI: 10.1530/ERC-13-0384.
9.Von Haller. Cited by Gratiot J.H. Carotid tumors: A collective review. Abstr. Surg. 1943; 7: 117-186.
10.Glenner G.G., Grimley P. M. Tumors of the extraadrenal paraganglion system, including chemoreceptors // Atlas of Tumor Pathology. Washington, DC: U.S. Armed Forces Institute of Pathology, 1974: 13-33.
11.Zak F.G., Lawson W. Anatomy and topography in the paraganglionic chemoreceptor system. 1st ed. New York: Springer-Verlag, 1982: 15-49.
12.Persky M.S., Setton A., Niimi Y., Hartman J., Frank D., Berenstein A. Combined endovascular and surgical treatment of head and neck paragangliomas. A team approach. Head Neck. 2002; 24: 423-431. DOI:10.1002/hed.10068.
13.Lee J.H., Barich F., Karnell L.H., Robinson R.A., Zhen W.K., Gantz B.J., Hoffman H.T.; American College of Surgeons Commission on Cancer; American Cancer Society. National Cancer Data Base report on malignant paragangliomas of the head and neck. Cancer. 2002; 94 (3): 730-737. DOI 10.1002/cncr.10252.
14.Del Guercio L., Narese D., Ferrara D., Butrico L., Padricelli A., Porcellini M. Carotid and vagal body paragangliomas. Transl. Med. UniSa. 2013; 6 (6): 11-15.
15.Szyma-nska A., Szyma-nski M., Czekajska-Chehab E., Golabek W., Szczerbo-Trojanowska M. Diagnosis and management of multiple paragangliomas of the head and neck. Eur. Arch. Otorhinolaryngol. 2015; 272 (8): 1991-1999. DOI: 10.1007/s00405-014-3126-z.
16.Williams M.D., Tischler A.S. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Paragangliomas. Head Neck Pathol. 2017; 11 (1): 88-95. DOI: 10.1007/s12105-017-0786-1.
17.Davila V.J., Chang J.M., Stone W.M., Fowl R.J., Bower T.C., Hinni M.L., Money S.R. Current surgical management of carotid body tumors. J. Vasc. Surg. 2016; 64 (6): 1703-1710. DOI: 10.1016/j.jvs.2016.05.076.
18.Langerman A., Athavale S.M., Rangarajan S.V., Sinard R.J., Netterville J.L. Natural history of cervical paragangliomas: outcomes of observation of 43 patients. Arch Otolaryngol. Head Neck Surg. 2012; 1383 (4): 341-345. DOI: 10.1001/archoto.2012.37.
19.Papaspyrou K., Mewes T., Rossmann H., Fottner C., Schneider-Raetzke B., Bartsch O., Schreckenberger M., Lackner K.J., Amedee R.G., Mann W.J. Head and neck paragangliomas: Report of 175 patients (1989-2010). Head Neck. 2012; 34 (5): 632-637. DOI:10.1002/hed.21790.
20.Mhatre A.N., Li Y., Gasperin A., Lalwani A.K. SDHB, SDHC, and SDHD mutation screen in sporadic and familial head and neck paragangliomas. Clin. Genet. 2004; 66: 461-466. DOI: 10.1111/j.1399-0004.2004.00328.x.
21.Burnichon N., Briere J.J., Libe R., Vescovo L., Riviere J., Tissier F., Jouanno E., Jeunemaitre X., Benit P., Tzagoloff A., Rustin P., Bertherat J., Favier J., Gimenez-Roqueplo A.P. SDHA is a tumor suppressor gene causing paraganglioma. Hum. Mol. Genet. 2010; 19: 3011-3020. DOI: 10.1093/hmg/ddq206.
22.Martucci V., Pacak K. Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment. Curr. Probl. Cancer. 2014; 38 (1): 7-41. DOI:10.1016/j.currproblcancer.2014.01.001.
23.Thabet M.H., Kotob H. Cervical paragangliomas: diagnosis, management and complications. J. Laryngol. Otol. 2001; 115: 467-474.
24.Lee K.Y., Oh Y.W., Noh H.J., Lee Y.J., Yong H.S., Kang E.U., Kim K.A., Lee N.J. Extraadrenal paragangliomas of the body: imaging features. Am. J. Roentgenol. 2006; 187 (2): 492-504. DOI: 10.2214/AJR.05.0370.
25.Myssiorek D., Ferlito A., Silver C.E., Rodrigo J.P., Baysal B.E., Fagan J.J., Suarez C., Rinaldo A. Screening for familial paragangliomas. Oral. Oncol. 2008; 44: 532-537. DOI: 10.1016/j.oraloncology.2007.06.010.
26.Jansen J.C., van den Berg R., Kuiper A., van der Mey A.G., Zwinderman A.H., Cornelisse C.J. Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal. Cancer. 2000; 88: 2811-2816.
27.Атанасян Л.А. Хемодектома. М.: Медицина,1969. 62 с.
28.O''Neill S., O''Donnell M., Harkin D., Loughrey M., Lee B., Blair P. A 22-year northern Irish experience of carotid body tumours. Ulster Med. J. 2011; 80 (3): 133-140.
29.Кармазановский Г.Г., Никитаев Н.С., Дан В.Н., Яшина Н.И., Шубин А.А., Щеголев А.И. Спиральная КТ в диагностике опухолей и других объемных образований в развилке сонных артерий. Медицинская визуализация. 2002; 1: 39-46.
30.Назимок Е.В., Сафронов С.Н., Крутова Т.В. Дифференциальная ультразвуковая диагностика каротидных хемо дектом и других опухолевых образований шеи. Здравоохранение Таджикистана. 2013; 3: 61-66.
31.Jianu D.C., Jianu S.N., Motoc A.G., Dan T.F., Poenaru M., Taban S., Cretu O.M. An evaluation on multidisciplinary management of carotid body paragangliomas: a report of seven cases. Rom. J. Morphol. Embryol. 2016; 57 (2): 853-859.
32.Berk M. Chemodektoma of the glomus intervagale: case report and review. Clin. Radial. 1961; 12: 219-226.
33.Аракелян В.С., Газимагомедов З.И., Абдулгасанов Р.А. Диагностика и результаты хирургического лечения каротидных хемодектом. Креативная кардиология. 2015; 2: 72-80. DOI: 10.15275/kreatkard.2015.02.07.
34.Белоцерковский И.В., Акинфеев В.В., Жуковец А.Г., Тризна Н.М. Хирургическое лечение параганглиом шеи. Опухоли головы и шеи. 2011; 3: 26-31.
35.Газимагомедов З.И. Параганглиомы шеи. Креативная кардиология. 2015; 1: 56-65. DOI: 10.15275/kreatkard.2015.01.06.
36.Lim J.Y., Kim J., Kim S.H., Lee S., Lim Y.C., Kim J.W., Choi E.C. Surgical treatment of carotid body paragangliomas: outcomes and complications according to the Shamblin classification. Clin. Exp. Otorhinolaryngol. 2010; 3: 91-95. DOI: 10.3342/ceo.2010.3.2.91.
37.Olsen W.L., Dillon W.P., Kelly W.M., Norman D., Brant-Zawadzki M., Newton T.H. MR imaging of paragangliomas. Am. J. Roentgenol. 1987; 148: 201-204. DOI:10.2214/ajr.148.1.201.
38.Wieneke J.A., Smith A. Paraganglioma: carotid body tumor. Head Neck Pathol. 2009; 3 (4): 303-306. DOI: 10.1007/s12105-009-0130-5.
39.Gravel G., Niccoli P., Rohmer V., Moulin G., Borson-Chazot F., Rousset P., Pasco-Papon A., Marcus C., Dubrulle F., Gouya H., Bidault F., Dupas B., Gabrillargues J., Caumont-Prim A., Hernigou A., Gimenez-Roqueplo A., Halimi P. The value of a rapid contrast-enhanced angio-MRI protocol in the detection of head and neck paragangliomas in SDHx mutations carriers: a retrospective study on behalf of the PGL.EVA investigators. Eur. Radiol. 2016; 26 (6): 1696-1704. DOI 10.1007/s00330-015-4024-5.
40.van den Berg R., Verbist B.M., Mertens B.J., van der Mey A.G., van Buchem M.A. Head and neck paragangliomas: improved tumor detection using contrast-enhanced 3D time-of-flight MR angiography as compared with fatsuppressed MR imaging techniques. Am. J. Neuro radiol. 2004; 25 (5): 863-870.
41.Capatina C., Ntali G., Karavitaki N., Grossman A.B. The management of head-and neck paragangliomas. Endocr. Relat. Cancer. 2013; 20: 291-305. DOI: 10.1530/ERC-13-0223.
42.Hamersley E.R., Barrows A., Perez A., Schroeder A., Castle J.T. Malignant Vagal Paraganglioma. Head Neck. Pathol. 2016; 10 (2): 201-205. DOI: 10.1007/s12105-015-0621-5.
43.Tong Y. Role of duplex ultrasound in the diagnosis and assessment of carotid body tumour: A literature review. Intractable Rare Dis. Res. 2012; 1 (3): 129-133. DOI: 10.5582/irdr.v1.3.129.
44.White G., Forbes M., Busch K., Harris J.P., Makeham V. Carotid body tumour or not. Ultrasound diagnostic features. Vascular 2007 Conference Handbook & Book of Abstracts. Melbourne, Australia, 2007. 72.
45.Offergeld C., Brase C., Yaremchuk S., Mader I., Rischke H.C., Glasker S., Schmid K.W., Wiech T., Preuss S.F., Suarez C., Kope-c T., Patocs A., Wohllk N., Malekpour M., Boedeker C.C., Neumann H.P. Head and neck paragangliomas: clinical and molecular genetic classification. Clinics (Sao Paulo). 2012; 67: 19-28.
46.Dickens W.J., Million R.R., Cassisi N.J., Singleton G.T. Chemodectomas arising in temporal bone structures. Laryngoscope. 1982; 92 (2): 188-191.
47.Gulya A.J. The glomus tumor and its biology. Laryngoscope. 1993; 103 (11, Pt 2, Suppl. 60): 7-15.
48.Brown J.S. Glomus jugulare tumors. Methods and difficulties of diagnosis and surgical treatment. Laryngoscope. 1967; 77 (1): 26-67. DOI: 10.1288/00005537-196701000-00004.
49.Mohan S., Hoeffner E., Bigelow D.C., Loevner L.A. Applications of magnetic resonance imaging in adult temporal bone disorders. Magn. Reson. Imaging Clin. N. Am. 2012; 20 (3): 545-572. DOI: 10.1016/j.mric.2012.06.001.
50.Subedi N., Prestwich R., Chowdhury F., Patel C., Scarsbrook A. Neuroendocrine tumours of the head and neck: anatomical, functional and molecular imaging and contemporary management. Cancer Imaging. 2013; 13 (3): 407-422. DOI:10.1102/1470-7330.2013.0034.
51.Devuyst L., Defreyne L., Praet M., Geukens S., Dhooge I. Treatment of glomus tympanicum tumors by preoperative embolization and total surgical resection. Am. J. Otolaryngol. 2016; 37 (6): 544-551. DOI: 10.1016/j.amjoto.2016.08.011.
52.Neves F., Huwart L., Jourdan G., Reizine D., Herman P., Vicaut E., Guichard J.P. Head and neck paragangliomas: value of contrast-enhanced 3D MR angiography. Am. J. Neuroradiol. 2008; 29: 883-889. DOI: 10.3174/ajnr.A0948.
53.Luna-Ortiz K., Rason-Ortiz M., Villavicencio-Valencia V., Herrera-Gomez A. Does Shamblin’s classification predict postoperative morbidity in carotid body tumors? A proposal to modify Shamblin’s classification? Eur. Arch. Otorhinolaryngol. 2006; 2: 171-175. DOI: 10.1007/s00405-005-0968-4.
54.Reigner. Cited by Lahey F.H., Warren K.W. A long-term appraisal of carotid tumors with remarks on their removal. Surg. Gynecol. Obstet. 1951; 92: 481-491.
55.Maydl. Cited by Byme J.J. Carotid body and allied tumors. Am. J. Surg. 1958; 95: 371-384.
56.Muhm M., Polterauer P., Gstottner W., Temmel A., Richling B., Undt G.,Niederle B., Staudacher M., Ehringer H. Diagnostic and therapeutic approaches to carotid body tumors: review of 24 patients. Arch. Surg. 1997; 132 (3): 279-284.
57.Gordon-Taylor G. On carotid tumours. Br. J. Surg. 1940; 28 (110): 163-172.
58.Shamblin W.R., Remine W.H., Sheps S.G., Harrison E.G. Carotid body tumor (chemodectoma). Clinicophatologic analysis of 90 cases. Am. J. Surg. 1971; 122 (6): 732-739.
59.Ma Y., Huang D., Liu L., Xiang M., Oghagbon E.K., Zhai S. Surgical treatment of carotid body tumour: a report of 39 cases and a new classification of carotid body tumour: our experience. Clin. Otolaryngol. 2014; 39 (4): 254-257. DOI: 10.1111/coa.12267.
60.Дан В.Н., Матякин Е.Г., Коков Л.С., Кармазановский Г.Г. Предварительная эмболизация при хирургическом лечении хемодектом шеи. Ангиология и сосудистая хирургия. 2000; 6 (2): 109-115.
61.Jackson R.S., Myhill J.A., Padhya T.A., McCaffrey J.C., McCaffrey T.V., Mhaskar R.S. The effects of preoperative embolization on carotid body paragangliomas surgery: a systematic review and meta-analysis. Otolaryngol. Head. Neck. Surg. 2015; 153 (6): 943-50. DOI: 10.1177/0194599815605323.
62.Dixon J.L., Atkins M.D., Bohannon W.T., Buckley C.J., Lairmore T.C. Surgical management of carotid body tumors: a 15-year single institution experience employing an interdisciplinary approach. Proc (Bayl. Univ. Med. Cent). 2016; 29 (1): 16-20.
63.Power A.H., Bower T.C., Kasperbauer J., Link M.J., Oderich G., Cloft H., Young WF.Jr., Gloviczki P. Impact of preoperative embolization on outcomes of carotid body tumor resections. J. Vasc. Surg. 2012; 56: 979-989. DOI: 10.1016/j.jvs.2012.03.037.
64.Bercin S., Muderris T., Sevil E., Gul F., Kilicarslan A., Kiris M. Efficiency of preoperative embolization of carotid body tumor. Auris Nasus Larynx. 2015; 42 (3): 226-230. DOI: 10.1016/j.anl.2014.10.013.
65.Bianchi L.C., Marchetti M., Brait L., Bergantin A., Milanesi I., Broggi G., Fariselli L. Paragangliomas of head and neck: a treatment option with CyberKnife radiosurgery. Neurol. Sci. 2009; 30: 479 - 485. DOI: 10.1007/s10072-009-0138-3.
66.Galland-Girodet S., Maire J.P., De-Mones E., Benech J., Bouhoreira K., Protat B., Demeaux H., Darrouzet V., Huchet A. The role of radiation therapy in the management of head and neck paragangliomas: Impact of quality of life versus treatment response. Radiother. Oncol. 2014; 111 (3): 463-467. DOI: 10.1016/j.radonc.2014.06.002.
67.Guss Z.D., Batra S., Limb C.J., Li G., Sughrue M.E., Redmond K., Rigamonti D., Parsa A.T., Chang S., Kleinberg L., Lim M. Radiosurgery of glomus jugulare tumors: a meta-analysis. Int. J. Radiation. Oncol. Biol. Phys. 2011; 81: 497-502. DOI: 10.1016/j.ijrobp.2011.05.006.

Paragangliomas of the Head and Neck: Epidemiology, Radiologic Diagnosis, Treatment

Paragangliomas of the head and neck are extremely rare tumors. During the period of professional activity, a radiologist can meet single patients with parangliomas. So it is important to know the main diagnostic signs when meeting with such patients, decause on-time diagnosis and treatment contribute to reduce surgical risk. The purpose of this review is to study the most common localizations of paragangliomas of head and neck and describe main visualization characteristics which are necessary for correct diagnosis and differential diagnosis.

Keywords:
параганглиома, хемодектома, опухоли головы и шеи, УЗИ, КТ, МРТ, paraganglioma, chemodectoma, head neck tumors, US, CT, MRI